Sun Pharma said has disputed the claims of the plaintiffs and defended these matters vigorously
The insurer has plans to provide the customers with services in these challenging times wherein Covid-19 is already a significant issue and the cyclone has only made matters worse
Ulip is a product which combines the benefits of investment and protection
The insurer rejected the claim citing delay in intimation. The Commission rejected this argument